President Donald Trump said Sunday that Americans may feel economic "pain" from his tariffs on key trading partners, but argued it would be "worth the price" to secure US interests.

Leading global drugmakers such as MSD Pharmaceuticals, Novartis, AstraZeneca, and Pfizer stand to benefit as it opens new opportunities to expand access to their medicines through PAPs.

FDA has upgraded the recall of over 6000 bags of Lay's Classic potato chips to the highest severity level in two US states.

The list of 36 drugs, which are exempt from basic customs duty, includes many expensive and imported medicines that can ...

A tuberculosis (TB) patient is said to be multidrug-resistant when the bacteria strain causing the infection has become ...

Healthcare experts lauded the announcement by Finance Minister Nirmala Sitharaman to setting up daycare cancer centres, ...

Select listed pharma player including Pfizer, Novartis India, AstraZeneca Pharma and GSK Pharma shall be the beneficiaries of ...

ALBUQUERQUE, N.M. — A federal grand jury has indicted a Navajo man, his father and a business partner on charges that they were running illegal marijuana growing operations in New Mexico and on the ...

The warrant was related to an investigation into a cocaine and fentanyl ring that expanded into Chittenden, Washington and ...

Cotecna Life Sciences India Private Limited, formerly Geo-Chem Pharma, is proud to announce the inauguration of its new, ...

A high-level meeting of police chiefs of seven states, NIA, NCB, Narcotics Control Bureau Haryana and Special Task Force Haryana officials was held in Panchkula on Friday to discuss strategy on ...

Despite humanity's scientific achievements and globalized economy, malnutrition remains a global issue. The United Nations ...